Published: 10/15/2026 | Author: Nikki Wisher

Diagnoses of opioid addiction among commercially insured Americans climbed 32.7% between 2022 and 2025, according to FAIR Health’s Opioid Tracker’s report. The national rate rose from 449 patients per 100,000 in 2022 to 596 per 100,000 in 2025.

The Opioid Tracker is a free interactive map of opioid use disorders among commercially insured patients.

The Opioid Crisis Continues

State-level variation is stark. Tennessee recorded the highest rate of commercially insured patients receiving treatment for opioid addiction at 1,551 patients per 100,000. After Tennessee came West Virginia at 1,528, Mississippi at 1,373, Arkansas at 1,320 and Delaware at 1,256. Even though all top five states have access to inpatient care and local Narcotics Anonymous chapters at the community level, each had more than twice the national rate.

Middle aged adults accounted for the largest share at 28%t of the national age distribution, and males made up 56% of diagnosed patients versus 43% female.

In general, opioid addiction is a chronic condition from prescription painkillers, heroin or illicit fentanyl. It changes brain chemistry in ways that make stopping without support extremely difficult. Withdrawal and overdose risk both rise after periods of reduced tolerance. The condition is diagnosed clinically and effective treatment combines medication with counseling rather than relying on willpower alone.

Changes in the Flow

The tracker shows where treatment dollars actually flow. Nationally, alcohol and substance abuse services accounted for 39% of all claim lines carrying an opioid use disorder diagnosis in 2025. The single highest-cost procedure was the weekly methadone medication-assisted treatment bundle, which made up 9.4%.

The treatment workforce is shifting too. Nurse practitioners were the fastest-growing specialty involved in drug treatment, with their share up 67% in 2025, followed by psychiatric nurses at 47% and emergency medicine at 44%. That expansion matters in rural counties hit hardest by fentanyl and other street opioids, where physician shortages have limited access to meds. 

Rising diagnosis rates also reflect more folks developing opioid addiction and being identified and connected to care, and the claims data alone cannot separate the two effects.

Harm Reduction & Treatment

Medication-assisted treatment remains the standard for opioid addiction. Tracker data shows it reaches more patients through a broader mix of providers. 

Carrying naloxone remains essential for anyone using street opioids, since fentanyl and its replacements continue to drive unpredictable potency. 

Peer support through Narcotics Anonymous meetings is free, anonymous and available in most communities.

NA Still a Top Tier Option

Opioid addiction responds to treatment, and the growing workforce numbers suggest care is becoming easier to reach. Feel free to browse our directory to find meetings filtered by location and format. 

Call 800-934-1582(Sponsored) to speak with an expert and to explore local options.